Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biliary Tract Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01099631
What this trial is testing

IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread

Who this might be right for
Cancer of the LiverLiver CancerHepatoma+2 more
Masonic Cancer Center, University of Minnesota 22
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Large-scale testing (Phase 3)Study completedNCT00262769
What this trial is testing

Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder Cancer
University College, London 324
Early research (Phase 1)Ended earlyNCT04209465
What this trial is testing

BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.

Who this might be right for
Solid Tumor
Black Diamond Therapeutics, Inc. 91
Early research (Phase 1)Ended earlyNCT01679405
What this trial is testing

BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer

Who this might be right for
Metastatic Disease
Johannes Gutenberg University Mainz 9
Early research (Phase 1)Study completedNCT00101972
What this trial is testing

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Who this might be right for
Cancer
MacroGenics 53
Not applicableActive Not RecruitingNCT05210322
What this trial is testing

Percutaneous Cholangiopancreatoscopy Registry

Who this might be right for
Biliary StonesCholangiocarcinoma, IntrahepaticBiliary Stricture+2 more
Johns Hopkins University 679
Not applicableLooking for participantsNCT03637569
What this trial is testing

The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer

Who this might be right for
Pancreas CancerCholangiocarcinomaGallbladder Cancer
Samsung Medical Center 1,000
Not applicableStudy completedNCT00779688
What this trial is testing

A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers

Who this might be right for
Pancreatic CancerBile Duct Cancer
Mauna Kea Technologies 130
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Early research (Phase 1)Looking for participantsNCT04900818
What this trial is testing

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorAdvanced CancerMetastatic Cancer+5 more
I-Mab Biopharma US Limited 330
Early research (Phase 1)WithdrawnNCT02856568
What this trial is testing

Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma

Who this might be right for
Non-Resectable CholangiocarcinomaRecurrent CholangiocarcinomaStage III Extrahepatic Bile Duct Cancer+10 more
Mayo Clinic
Testing effectiveness (Phase 2)Ended earlyNCT06024174
What this trial is testing

BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 5
Not applicableEnrolling By InvitationNCT05745233
What this trial is testing

Intraperitoneal Immune Checkpoint Inhibitor for Malignant Ascites

Who this might be right for
Malignant Ascites
China Medical University Hospital 30
Post-approval studies (Phase 4)Study completedNCT00980889
What this trial is testing

RCT Steel (Wallstent®) vs Nitinol (Wallflex®) Bile Duct Stent for Palliation of Malignant Obstruction

Who this might be right for
Biliary Tract NeoplasmsPancreatic NeoplasmsStent Occlusion
Stockholm South General Hospital 400
Testing effectiveness (Phase 2)Looking for participantsNCT06280508
What this trial is testing

Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer

Who this might be right for
Resectable Intrahepatic Cholangiocarcinoma With High Risk of Recurrence
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 40
Early research (Phase 1)Study completedNCT01927965
What this trial is testing

Study of Minnelide™ in Patients With Advanced GI Tumors

Who this might be right for
Advanced Gastrointestinal Tumors
Minneamrita Therapeutics LLC 45
Testing effectiveness (Phase 2)Looking for participantsNCT05489211
What this trial is testing

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Who this might be right for
Endometrial CancerGastric CancerMetastatic Castration-resistant Prostate Cancer+4 more
AstraZeneca 454
Not applicableStudy completedNCT02649712
What this trial is testing

Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction

Who this might be right for
CholangiocarcinomaGallbladder CarcinomaHepatocellular Carcinoma
Xuzhou Central Hospital 72
Testing effectiveness (Phase 2)Ended earlyNCT05009953
What this trial is testing

Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract CancerIntrahepatic CholangiocarcinomaExtrahepatic Cholangiocarcinoma+1 more
CSPC Ouyi Pharmaceutical Co., Ltd. 17
Next Page